Cross-Disorder Group of the Psychiatric Genomics Consortium, Lee H, Ripke S, et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet. 2013;45(9):984-94. doi:10.1038/ng.2711.

St Pourcain B, Robinson EB, Anttila V, et al. ASD and schizophrenia show distinct developmental profiles in common genetic overlap with population-based social communication difficulties. Mol Psychiatry. 2018;23(2):263-270. doi:10.1038/mp.2016.198.

Monteiro P, Feng G. SHANK proteins: roles at the synapse and in autism spectrum disorder. Nat Rev Neurosci. 2017;18(3):147-157. doi:10.1038/nrn.2016.183.

Talkowski ME, Rosenfeld JA, Blumenthal I, et al. Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries. Cell. 2012;149(3):525-37. doi:10.1016/j.cell.2012.03.028.

Lim ET, Raychaudhuri S, Sanders SJ, et al. Rare complete knockouts in humans: population distribution and significant role in autism spectrum disorders. Neuron. 2013;77(2):235-42. doi:10.1016/j.neuron.2012.12.029.

Robinson EB, Howrigan D, Yang J, et al. Response to ’Predicting the diagnosis of autism spectrum disorder using gene pathway analysis’. Mol Psychiatry. 2014;19(8):859-61. doi:10.1038/mp.2013.125.

Fromer M, Pocklington AJ, Kavanagh DH, et al. De novo mutations in schizophrenia implicate synaptic networks. Nature. 2014;506(7487):179-84. doi:10.1038/nature12929.

Manzini C, Xiong L, Shaheen R, et al. CC2D1A regulates human intellectual and social function as well as NF-κB signaling homeostasis. Cell Rep. 2014;8(3):647-55. doi:10.1016/j.celrep.2014.06.039.

Samocha KE, Robinson EB, Sanders SJ, et al. A framework for the interpretation of de novo mutation in human disease. Nat Genet. 2014;46(9):944-50. doi:10.1038/ng.3050.

Duda M, Kosmicki JA, Wall DP. Testing the accuracy of an observation-based classifier for rapid detection of autism risk. Transl Psychiatry. 2014;4:e424. doi:10.1038/tp.2014.65.